Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet

American Journal of Kidney Diseases

Volumn 31, Issue 6 SUPPL.1, 1998, Pages

  Starzl, T E ^a   Todo, S ^a   Demetris, A J ^a   Fung, J J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Clinical trials; Cyclosporine; Kidney; Liver; Regulatory; Tacrolimus; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; EURO COLLINS SOLUTION; LYMPHOCYTE ANTIBODY; PREDNISONE; TACROLIMUS; UNIVERSITY OF WISCONSIN SOLUTION;

CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CONTROL; DRUG COST; DRUG MONITORING; FOOD AND DRUG ADMINISTRATION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; ORAL DRUG ADMINISTRATION;

EID: 0031800553     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9631858     Document Type: Conference Paper

References (43)